In a last-minute move Wednesday, the Trump administration excluded pharmaceuticals from its retaliatory tariffs, giving ...

This week, the Trump administration followed through on its planned mass layoffs at agencies under the US Department of ...

The pharmaceutical industry avoided immediate tariffs under President Donald Trump’s latest trade actions, though future levies remain a possibility. Here are four things to know: ...

Marcel Botha, CEO of 10XBeta, identifies the most significant technological innovations in medical device manufacturing that ...

The recent imposition of a 27 per cent reciprocal tariff on Indian exports by the United States, while exempting the ...

Pharmaceutical products will be spared from sweeping tariffs on major U.S. trade partners for now, a small victory for drug companies who have been lobbying for an exemption from levies.

Maria Lowe, Ph.D., associate vice president of Pharmaceutical Intelligence at Institute for Clinical and Economic Review ...

Indian pharmaceutical exports to the U.S. were valued at approximately USD 8 billion, with the industry witnessing an 8 ...

Dilip Shanghvi is not one for flamboyant statements or headline-grabbing moves. Yet, over the decades, the soft-spoken ...

With an increasing demand for NHS services, technology is being positioned as a critical tool in eliminating inefficiencies ...